Edition:
United States

Australian Pharmaceutical Industries Ltd (API.AX)

API.AX on Australia Stock Exchange

1.67AUD
18 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.67
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,158,829
52-wk High
$2.38
52-wk Low
$1.41

Chart for

About

Australian Pharmaceutical Industries Limited is a pharmaceutical distributor, and health and beauty retailer. The Company operates through two segments: Australia, which is engaged in the distribution of pharmaceutical, medical, health, beauty and lifestyle products to pharmacies, the purchase and sale of various health, beauty... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $807.58
Shares Outstanding(Mil.): 492.43
Dividend: 0.04
Yield (%): 4.27

Financials

  Industry Sector
P/E (TTM): -- 22.70 16.04
EPS (TTM): -- -- --
ROI: -- 12.02 34.69
ROE: -- 13.56 15.46

BRIEF-Wattle Health ‍Entered Into Distribution Arrangement With Australian Pharmaceutical Industries

* ‍ENTERED INTO A DISTRIBUTION ARRANGEMENT WITH AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED​ Source text for Eikon: Further company coverage:

Dec 06 2017

BRIEF-Australian Pharmaceutical Industries posts ‍FY profit for period attributable to members $52.371 mln

* ‍FY profit for period attributable to members $52.371 million versus $51.670 million​

Oct 18 2017

BRIEF-Australian Pharmaceutical Industries responds to media speculation

* Notes media speculation today that it is considering a potential acquisition of laser clinics australia

Aug 06 2017

BRIEF-Australian Pharmaceutical Industries revises FY profit guidance

* Now expects full year net profit after tax to be approximately 5% up on FY16

Aug 02 2017

Earnings vs. Estimates